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Abstract
The recent Ebola virus disease (EVD) outbreaks in 2021 exemplify how sexual and reproductive health services are
too often considered unessential during health emergencies. Bleeding for reasons other than EVD, such as
pregnancy complications or rape, can be construed as EVD symptoms, reinforcing fear and stigmatisation, and
delaying timely access to adequate care. In this commentary, we urgently call on all humanitarian actors to
integrate the Minimum Initial Services Package for Sexual and Reproductive Health in Crisis Situations into current
and future EVD preparedness and response efforts.
Background
Sexual and reproductive health (SRH) conditions are
among the leading causes of mortality in women of re-
productive age, with countries beset by fragility and low-
resilience health systems accounting for two-thirds of
maternal deaths worldwide [1]. Ebola virus disease
(EVD) is a severe zoonotic illness with an average case
fatality rate of 50%. It spreads among humans through
bodily fluids. Past EVD outbreaks suggest that halting
health-care services judged to be unrelated to the epi-
demic response caused more deaths than did the epi-
demic itself [2].
At the intersection of EVD and SRH, poor health out-
comes arise from the disruption of life-saving services,
including maternal and neonatal care and care for indi-
viduals experiencing abortion complications, sexual vio-
lence, and other forms of gender-based violence [3].
Women and girls are at risk of gender-based violence
due to increased exposure to perpetrators during cur-
fews, school closure, and economic hardship, among
others [4]. The mortality among EVD-positive pregnant
women is not higher than that of non-pregnant individ-
uals with EVD [5]. However, almost all EVD-affected
pregnancies end in miscarriage, stillbirths, or neonatal
deaths [6]. EVD-positive pregnant women can show
signs and symptoms not meeting EVD case definitions
[7]. Conversely, bleeding for reasons other than EVD,
such as pregnancy, rape, and menses, can be misinter-
preted as EVD symptoms, reinforcing fear and stigma-
tisation by the community and health-care providers,
delaying timely access to adequate care [8].
The 2021 EVD outbreaks in Guinea and the Demo-
cratic Republic of Congo exemplify how regional and na-
tional humanitarian actors must actively safeguard SRH
interventions in contingency plans, resource mobilisa-
tion, and responses. Consequently, the Inter-Agency
Working Group for Reproductive Health in Crises issued
field guidance on SRH and EVD [9]. The guidance builds
on the prerequisite that health ministries and humani-
tarian stakeholders, including SRH leaders, should co-
ordinate and plan to ensure that EVD preparedness and
response integrate SRH services, supplies, and referral
mechanisms. To enable the systematic prioritisation of
SRH in current and future EVD responses—and
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: nguyentoan.tran@uts.edu.au
1Australian Centre for Public and Population Health Research, Faculty of
Health, University of Technology Sydney, Sydney, NSW, Australia
2Faculty of Medicine, University of Geneva, Geneva, Switzerland
Full list of author information is available at the end of the article
Tran et al. Conflict and Health           (2021) 15:57 
https://doi.org/10.1186/s13031-021-00392-3
minimise SRH-related deaths—the following recommen-
dations should also be considered.
First, all essential services and supplies defined by
the Minimum Initial Services Package (MISP) for
SRH in Crisis Situation, a standard in humanitarian
response, should be prioritised during the whole EVD
response [10]. It includes intrapartum care, emergency
obstetric and neonatal care, post-abortion care, safe
abortion care to the full extent of the law, contracep-
tion, care for rape survivors, and prevention and
treatment of HIV and other sexually-transmitted in-
fections. Women and adolescent girls with suspected
EVD should be offered pregnancy testing at EVD tri-
age posts—backed by standard operating procedures
that guarantee safe and dignified isolation until EVD
ascertainment and effective referrals of confirmed
cases to EVD treatment centres [11]. These centres
should have adequate SRH supplies, personnel, and
protocols, including for emergency obstetric and neo-
natal care, and offer counselling on potential out-
comes and options to individuals testing positive for
EVD and pregnancy. Equally important is safer sex
and contraceptive counselling for all individuals of re-
productive age, regardless of EVD and pregnancy
status.
Second, engaging health-care workers, EVD survi-
vors, and representatives of the community and tar-
geted audiences is crucial for crafting clear and
relevant public health information. This information
should reiterate the importance of seeking care for
childbirth and other SRH needs and medical emer-
gencies. Risk communication and community engage-
ment strategies should cover SRH and EVD, the risk
of poor health outcomes for women and girls, help
individuals differentiate “inexplicable bleeding” (EVD)
from “explicable bleeding” (e.g., menses)—and address
related stigma. No less critical is information about
contraception, safer sex, breastfeeding, avoiding unsafe
home births, and where to access care, including for
Ebola virus vaccine.
Third, infection prevention and control measures, in-
cluding personal protective equipment, should be part of
managing labour and deliveries, abortion-related care,
and any procedures with bodily fluid contact, such as
rape survivor care, regardless of EVD status. Reliable
supplies to enforce such precautions in both EVD treat-
ment centres and SRH facilities should be thoroughly
planned during coordination meetings. These facilities
should also optimise waste management practices of
used menstrual hygiene products and pregnancy-related
fluids and tissues, including safe placenta disposal. Not
least, SRH providers, including community midwives
and other frontline health-care workers, must be priori-
tized in national Ebola vaccination programmes.
Conclusion
Our guidance on SRH and EVD was issued to galvanise
country and regional stakeholders to safeguard essential
health-care services, including SRH, during EVD pre-
paredness and response efforts. We call upon them to
treat life-saving SRH services as core constituents of the
overall EVD intervention package, one that does not en-
feeble but bolsters health-care systems while meeting
the health needs of women, girls, and the whole
community.
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